﻿<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet href="style" type="text/css"?>
<rss version="2.0">
  <channel>
    <title>European Industrial Pharmacists Group (EIPG) RSS Feed</title>
    <link>http://www.eipg.eu/</link>
    <description>Latest information from the EIPG Website</description>
    <language>en</language>
    <managingEditor>communications@eipg.eu (Vice-President Communications)</managingEditor>
    <webMaster>communications@eipg.eu (Vice-President Communications)</webMaster>
    <lastBuildDate>Mon, 07 Jun 2010 22:17:59 +0200</lastBuildDate>
    <image>
      <url>http://www.eipg.eu/images/logaliten.jpg</url>
      <link>http://www.eipg.eu/</link>
      <title>European Industrial Pharmacists Group (EIPG) RSS Feed</title>
    </image>
    <item>
      <title>EIPG feedback on revised Annex 16.</title>
      <link>http://www.eipg.eu/indexposition papers.htm</link>
      <description>Comments from the European Industrial Pharmacists Group on the Commission’s Concept Paper on the Revision of Annex 16.</description>
      <pubDate>Sun, 05 Feb 2012 16:04:15 +0100</pubDate>
      <guid isPermaLink="false">ECC29A5A-2CE5-4D10-AA24-E8F3F22D9DAA</guid>
    </item>
    <item>
      <title>Council of Europe draws up MEDICRIME Convention.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>To combat counterfeiting of medical products and related crime the Council of Europe has drawn up an international convention – the MEDICRIME Convention – a legally binding instrument criminalising all acts of counterfeiting of medical products. </description>
      <pubDate>Sun, 05 Feb 2012 15:53:00 +0100</pubDate>
      <guid isPermaLink="false">2A879185-F9E4-4A1F-80FB-CA445A42CE1E</guid>
    </item>
    <item>
      <title>Updated EIPG Guidelines on Good Distribution Practices.</title>
      <link>http://www.eipg.eu/indexguides.htm</link>
      <description>The European Industrial Pharmacists Group has updated its Guidelines on Good Distribution Practices of Medicinal Products to reflect changes in the WHO good distribution practices for pharmaceutical products.</description>
      <pubDate>Wed, 25 Jan 2012 23:24:14 +0100</pubDate>
      <guid isPermaLink="false">2365508F-E16B-4744-818A-244D79D4E071</guid>
    </item>
    <item>
      <title>Delegated act on the principles and guidelines of good manufacturing practice for active substances in medicinal products for human use.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>Directive 2011/62/EU places an obligation on Member States to take appropriate measures to ensure that manufacturers of active substances on their territory comply with good manufacturing practice ('GMP') for active substances. It also places an obligation on the Commission to adopt, by means of delegated acts, the principles and guidelines of good manufacturing practice for active substances. This concept paper is being released for public consultation with a view to preparing the delegated act.</description>
      <pubDate>Tue, 24 Jan 2012 21:33:02 +0100</pubDate>
      <guid isPermaLink="false">C7B611D0-3A9B-42DF-84EC-3357D50EA065</guid>
    </item>
    <item>
      <title>Qualification of novel methodologies for drug development.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Regulatory and procedural guideline: Qualification of novel methodologies for drug development: guidance to applicants.</description>
      <pubDate>Tue, 24 Jan 2012 21:31:16 +0100</pubDate>
      <guid isPermaLink="false">9999C2EF-3514-47BF-851A-AFF324A23E9D</guid>
    </item>
    <item>
      <title>Draft guideline on active-substance-master-file procedure (revision 3).</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Scientific guideline: Draft guideline on active-substance-master-file procedure (revision 3), draft: consultation open.</description>
      <pubDate>Tue, 24 Jan 2012 21:29:50 +0100</pubDate>
      <guid isPermaLink="false">1F2A6FC5-607C-484F-9380-8A8B673CEBFF</guid>
    </item>
    <item>
      <title>EIPG feedback on revised GDP guidelines.</title>
      <link>http://www.eipg.eu/indexposition papers.htm</link>
      <description>Comments from the European Industrial Pharmacists Group on the Commission’s Revised Guidelines on Good Distribution Practice of Medicinal Products for Human Use.</description>
      <pubDate>Sat, 31 Dec 2011 12:57:09 +0100</pubDate>
      <guid isPermaLink="false">834CAC5E-5B9F-4151-8F2B-9B1E5FAA9BEA</guid>
    </item>
    <item>
      <title>Draft guideline on risk characterisation and assessment of Maximum Residue Limits (MRL) for biocides.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Scientific guideline: Draft guideline on risk characterisation and assessment of Maximum Residue Limits (MRL) for biocides, draft: consultation open.</description>
      <pubDate>Thu, 22 Dec 2011 12:52:44 +0100</pubDate>
      <guid isPermaLink="false">3567335D-6BCE-40F0-8AF0-1D4F7C668FB3</guid>
    </item>
    <item>
      <title>Draft VICH GL51: Quality: statistical evaluation of stability data.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Scientific guideline: Draft VICH GL51: Quality: statistical evaluation of stability data, draft: consultation open.</description>
      <pubDate>Thu, 22 Dec 2011 12:52:18 +0100</pubDate>
      <guid isPermaLink="false">59A656FA-36D7-46F4-9F9D-EE7CB4822623</guid>
    </item>
    <item>
      <title>Draft VICH GL50: Biologicals: testing harmonisation of criteria to waive target animal batch safety testing for inactivated vaccines for veterinary use.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Scientific guideline: Draft VICH GL50: Biologicals: testing harmonisation of criteria to waive target animal batch safety testing for inactivated vaccines for veterinary use, draft: consultation open.</description>
      <pubDate>Thu, 22 Dec 2011 12:51:43 +0100</pubDate>
      <guid isPermaLink="false">880685CA-9F67-451B-BD33-6A2D291E3591</guid>
    </item>
    <item>
      <title>Draft VICH GL34: Biologicals: testing for the detection of mycoplasma contamination.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Scientific guideline: Draft VICH GL34: Biologicals: testing for the detection of mycoplasma contamination, draft: consultation open.</description>
      <pubDate>Thu, 22 Dec 2011 12:50:53 +0100</pubDate>
      <guid isPermaLink="false">A25C1101-C49D-4B6D-8902-C8BFC988F93A</guid>
    </item>
    <item>
      <title>ICH guideline S2 (R1) - Genotoxicity testing and data interpretation for pharmaceuticals intended for human use.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Scientific guideline: ICH guideline S2 (R1) - Genotoxicity testing and data interpretation for pharmaceuticals intended for human use, adopted.</description>
      <pubDate>Mon, 19 Dec 2011 22:17:34 +0100</pubDate>
      <guid isPermaLink="false">530ABB7F-392B-4343-AF3C-962A792D463E</guid>
    </item>
    <item>
      <title>Guideline on the warning on transmissible agents in summary of product characteristics (SmPCs) and package leaflets for plasma-derived medicinal products.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>The European Medicines Agency have published: Scientific guideline: Guideline on the warning on transmissible agents in summary of product characteristics (SmPCs) and package leaflets for plasma-derived medicinal products, adopted.</description>
      <pubDate>Mon, 19 Dec 2011 22:16:30 +0100</pubDate>
      <guid isPermaLink="false">6743D36D-9150-463E-9457-62A2AD867B74</guid>
    </item>
    <item>
      <title>Implementing act on the requirements for the assessment of the regulatory framework applicable to the manufacturing of active substances of medicinal products for human use.</title>
      <link>http://www.eipg.eu/indexevents.htm</link>
      <description>Directive 2011/62/EU introduces EU-wide rules for the importation of active substances. Article 111b(2) of Directive 2001/83/EC provides that the Commission adopts an implementing measure to apply these requirements. This concept paper is being rolled out for public consultation with a view to preparing this implementing act.</description>
      <pubDate>Sun, 18 Dec 2011 20:59:52 +0100</pubDate>
      <guid isPermaLink="false">E25B1DE0-9C20-413A-9421-F64B3C1FD696</guid>
    </item>
    <item>
      <title>Issue 11 of european Industrial Pharmacy.</title>
      <link>http://www.industrialpharmacy.eipg.eu/indexissues.htm</link>
      <description>The&amp;nbsp;11th issue (December 2011)&amp;nbsp;of the european Industrial Pharmacy journal has been published and is available from the journal's website.</description>
      <pubDate>Sat, 10 Dec 2011 00:20:00 +0100</pubDate>
      <guid isPermaLink="false">FED98015-6E2F-4FC4-ACB7-7FC6A6A84C3D</guid>
    </item>
  </channel>
</rss>
